No title
Antimicrobial resistance is a growing global health threat, and once curable infections are now becoming life-threatening. Still, the discovery of new antibiotics continues to decline. Targeted protein degradation potentially offers a novel antibacterial strategy by leveraging cellular degradation pathways to eliminate bacterial proteins. BacPROTACs represent a promising approach, as they utilize
